E-LIB Suche - Ergebnisse für: Dogterom, Peter

1

A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With E..:

France, Nicholas P. ; Rubino, Christopher ; Safir, M. Courtney...
Clinical Pharmacology in Drug Development. 12 (2023) 6 - p. 625-638 , 2023

Link: https://doi.org/10.1002/..

2

Safety, Tolerability, Pharmacokinetics and Initial Pharmaco..:

Bourdès, Valérie ; Dogterom, Peter ; Aleman, André...
Neurology and Therapy. 11 (2022) 3 - p. 1353-1374 , 2022

Link: https://doi.org/10.1007/..

3

Comparison of the Pharmacokinetic Profiles of Trientine Tet..:

Weiss, Karl Heinz ; Thompson, Catherine ; Dogterom, Peter...
European Journal of Drug Metabolism and Pharmacokinetics. 46 (2021) 5 - p. 665-675 , 2021

Link: https://doi.org/10.1007/..

4

Population Pharmacokinetic/Pharmacodynamic Modeling of Glen..:

Renaud, Lionel ; Lebozec, Kristell ; Voors‐Pette, Christine...
The Journal of Clinical Pharmacology. 60 (2020) 9 - p. 1198-1208 , 2020

Link: https://doi.org/10.1002/..

5

Effect of Rifampin‐Mediated OATP1B1 and OATP1B3 Transporter..:

Schilling, Uta ; Dingemanse, Jasper ; Voors‐Pette, Christine...
Clinical and Translational Science. 13 (2020) 5 - p. 886-890 , 2020

Link: https://doi.org/10.1111/..

6

Influence of Rifampin‐Mediated Organic Anion‐Transporting P..:

Juif, Pierre‐Eric ; Voors‐Pette, Christine ; Ufer, Mike..
Clinical and Translational Science. 12 (2019) 5 - p. 440-444 , 2019

Link: https://doi.org/10.1111/..

7

Asenapine pharmacokinetics and tolerability in a pediatric ..:

Dogterom, Peter ; Riesenberg, Robert ; de Greef, Rik...
Drug Design, Development and Therapy. 12 (2018) - p. 2677-2693 , 2018

Link: https://doi.org/10.2147/..

8

The effect of food on the high clearance drug asenapine aft..:

Dogterom, Peter ; de Greef, Rik ; Peeters, Pierre A. M.
European Journal of Clinical Pharmacology. 71 (2015) 1 - p. 65-74 , 2015

Link: https://doi.org/10.1007/..

9

Application of Absorption Modeling to Predict Bioequivalenc..:

Mitra, Amitava ; Kesisoglou, Filippos ; Dogterom, Peter
AAPS PharmSciTech. 16 (2014) 1 - p. 76-84 , 2014

Link: https://doi.org/10.1208/..

10

Development and validation of automated SPE‐HPLC‐MS/MS meth..:

de Boer, Theo ; Meulman, Erik ; Meijering, Henri...
Biomedical Chromatography. 26 (2012) 12 - p. 1461-1463 , 2012

Link: https://doi.org/10.1002/..

11

Examination of Org 26576, an AMPA receptor positive alloste..:

Nations, Kari R ; Dogterom, Peter ; Bursi, Roberta...
Journal of Psychopharmacology. 26 (2012) 12 - p. 1525-1539 , 2012

Link: https://doi.org/10.1177/..

12

Valproate Reduces the Glucuronidation of Asenapine Without ..:

Gerrits, Mireille G.F. ; de Greef, Rik ; Dogterom, Peter.
The Journal of Clinical Pharmacology. 52 (2012) 5 - p. 757-765 , 2012

Link: https://doi.org/10.1177/..

13

Asenapine Safety, Tolerability, and Pharmacokinetics After ..:

Dogterom, Peter ; Timmer, Cees ; de Greef, Rik...
Clinical Pharmacology in Drug Development. 1 (2012) 4 - p. 131-143 , 2012

Link: https://doi.org/10.1177/..

14

Translational PK–PD modelling of molecular target modulatio..:

Bursi, Roberta ; Erdemli, Gul ; Campbell, Robert...
Psychopharmacology. 218 (2011) 4 - p. 713-724 , 2011

Link: https://doi.org/10.1007/..

15

Quantification of asenapine and three metabolites in human ..:

de Boer, Theo ; Meulman, Erik ; Meijering, Henri...
Biomedical Chromatography. 26 (2011) 2 - p. 156-165 , 2011

Link: https://doi.org/10.1002/..